phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Phase 3 Study: New Therapy Keeps Gastrointestinal Cancer Care on Course When Low Platelets Are an Obstacle

A phase 3 trial in NEJM shows the drug romiplostim can help gastrointestinal cancer patients stay on schedule with chemotherapy despite low platelet counts. In the RECITE study, 84% of patients receiving the drug avoided dose delays or reductions, compared with 36% on placebo--suggesting a new way to prevent a common treatment disruption.

March 17, 2026


March 28 2026

March 27 2026

March 26 2026

March 25 2026

March 24 2026

March 23 2026

March 22 2026

March 21 2026

March 20 2026

March 19 2026

March 18 2026

March 17 2026

March 16 2026

March 15 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy